InvestorsHub Logo

cowtown jay

12/20/21 4:14 PM

#34716 RE: pipette #34713

As a matter of fact, "On December 20, 2021, Novavax, Inc. (the “Company”) issued a press release announcing that the European Commission (the “EC”) granted the Company conditional marketing authorization for its Nuvaxovid™ COVID-19 Vaccine."

https://ih.advfn.com/stock-market/NASDAQ/novavax-NVAX/stock-news/86858298/current-report-filing-8-k